Long-term investment company RECM and Calibre (RACP) — headed by asset-management personalities Piet Viljoen and Jan van Niekerk — easily outsprinted the JSE in the year to March. Results released on Wednesday showed RACP increased net asset value — the best gauge of performance of an investment company — a whopping 39% to R27.35 per share. Over the same period the JSE’s all share index managed a much more modest 2.5% total return. The largest component of the return stemmed from dividends triggered by the sale of RACP’s indirect stake in recently listed healthcare retailer Dis-Chem. Viljoen said this partially reflected the way the company’s investment in Dis-Chem was structured — via Fledge Holdings, "as a result of which the proceeds from the sale of this investment of R324m was paid out as a dividend". During the year, RACP also sold off minority interests in boutique hotel group Gooderson, American Homes and Afrocentric Health for a small profit. About R250m was spent on invest...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.